Miles Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-750
| Closed | -$235K | – | 193 |
|
2019
Q2 | $235K | Buy |
750
+21
| +3% | +$6.58K | 0.19% | 143 |
|
2019
Q1 | $299K | Hold |
729
| – | – | 0.26% | 103 |
|
2018
Q4 | $272K | Hold |
729
| – | – | 0.27% | 108 |
|
2018
Q3 | $295K | Hold |
729
| – | – | 0.24% | 112 |
|
2018
Q2 | $251K | Hold |
729
| – | – | 0.15% | 140 |
|
2018
Q1 | $251K | Buy |
+729
| New | +$251K | 0.14% | 157 |
|
2017
Q3 | – | Sell |
-1,136
| Closed | -$558K | – | 217 |
|
2017
Q2 | $558K | Hold |
1,136
| – | – | 0.3% | 60 |
|
2017
Q1 | $440K | Buy |
1,136
+425
| +60% | +$165K | 0.25% | 64 |
|
2016
Q4 | $261K | Sell |
711
-155
| -18% | -$56.9K | 0.16% | 102 |
|
2016
Q3 | $348K | Sell |
866
-299
| -26% | -$120K | 0.24% | 69 |
|
2016
Q2 | $407K | Buy |
1,165
+331
| +40% | +$116K | 0.28% | 80 |
|
2016
Q1 | $301K | Buy |
+834
| New | +$301K | 0.2% | 114 |
|